Marksans Pharma Limited has informed the Exchange regarding a press release dated August 02, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary in UK Relonchem Limited, receives Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets".